enVVeno Medical
NVNO
17 hedge funds and large institutions have $954K invested in enVVeno Medical in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
2.04% less ownership
Funds ownership: 15.33% → 13.29% (-2%)
6% less capital invested
Capital invested by funds: $1.02M → $954K (-$64.7K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$5.81K |
| 2 |
Barclays
London,
United Kingdom
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$106K |
| 2 |
BlackRock
New York
|
-$15.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.61K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.27K |
| 5 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$690 |
NVNO Hedge Fund Activity: Q2 2026 in Review
17 of the 8,303 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2026, worth a combined $954K — down 6.3% from $1.02M a quarter earlier.
Fund positioning in NVNO was balanced in Q2 2026: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 6 trimmed.
The largest buyer was Mirae Asset Global Investments, opening a new position worth an estimated $5.81K. The largest seller was Geode Capital Management, exiting entirely with an estimated $106K sold.
- 17 institutional investors held enVVeno Medical (NVNO) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $954K of enVVeno Medical stock for Q2 2026, down 6.3% quarter-over-quarter.
- 3 funds opened new enVVeno Medical positions in Q2 2026 and 3 closed out, a net change of 0 holders.
- The largest enVVeno Medical buyer in Q2 2026 was Mirae Asset Global Investments, an estimated $5.81K added.
- The largest enVVeno Medical seller in Q2 2026 was Geode Capital Management, an estimated $106K sold.
Based on aggregated 13F filings for Q2 2026.